Levin Capital Strategies’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Levin Capital Strategies's MRK Position: Q1 2026 in Review
Levin Capital Strategies opened a new position in Merck (MRK) in Q1 2026: 13,322 shares worth $1.6M. The stake represents 0.12% of the portfolio and ranks #106 among its holdings. This is a return to the name: Levin Capital Strategies previously reported a position in MRK as recently as Q2 2022.
Levin Capital Strategies first reported a position in MRK in Q2 2013 and has held it in 23 quarters since. The position peaked at $249M in Q4 2013. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Levin Capital Strategies held 13,322 shares of Merck worth $1.6M as of Q1 2026.
- Merck was a new Levin Capital Strategies position in Q1 2026.
- Merck made up 0.12% of Levin Capital Strategies's portfolio in Q1 2026, its #106 holding.
- Levin Capital Strategies first reported a position in Merck in Q2 2013 and has held it in 23 quarters since.
- Levin Capital Strategies's Merck position peaked at $249M in Q4 2013.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Levin Capital Strategies's 13F filing for Q1 2026, filed 13 May 2026.